Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 12, 2021

SELL
$19.05 - $28.32 $2.52 Million - $3.74 Million
-132,144 Closed
0 $0
Q1 2021

May 11, 2021

SELL
$11.86 - $21.77 $361,374 - $663,331
-30,470 Reduced 18.74%
132,144 $2.41 Million
Q4 2020

Feb 11, 2021

BUY
$7.25 - $11.76 $1.18 Million - $1.91 Million
162,614 New
162,614 $1.88 Million
Q1 2020

May 13, 2020

SELL
$3.15 - $7.39 $635,780 - $1.49 Million
-201,835 Closed
0 $0
Q4 2019

Feb 11, 2020

BUY
$5.01 - $8.16 $454,041 - $739,516
90,627 Added 81.49%
201,835 $1.55 Million
Q3 2019

Nov 13, 2019

BUY
$5.07 - $7.08 $563,824 - $787,352
111,208 New
111,208 $589,000
Q1 2019

May 13, 2019

SELL
$3.56 - $4.82 $1.26 Million - $1.71 Million
-353,982 Closed
0 $0
Q4 2018

Feb 13, 2019

BUY
$4.04 - $6.75 $238,796 - $398,979
59,108 Added 20.05%
353,982 $1.45 Million
Q3 2018

Nov 08, 2018

BUY
$4.28 - $7.32 $1.26 Million - $2.16 Million
294,874 New
294,874 $2.02 Million

Others Institutions Holding CDMO

About Avid Bioservices, Inc.


  • Ticker CDMO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,167,500
  • Market Cap $776M
  • Description
  • Avid Bioservices, Inc., a contract development and manufacturing organization, provides process development and current good manufacturing practices (CGMP) clinical and commercial manufacturing services focused on biopharmaceutical drug substances derived from mammalian cell culture. The company produces monoclonal antibodies and recombinant pro...
More about CDMO
Track This Portfolio

Track Eam Investors, LLC Portfolio

Follow Eam Investors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eam Investors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Eam Investors, LLC with notifications on news.